Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heyue Zhou

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Selection and characterization of human monoclonal antibodies against Abrin by phage displayHeyue Zhou, Bin Zhou, Hongzheng Ma, et al.
The Journal of Biological Chemistry|February 3, 2005
Solution structure of AF-6 PDZ domain and its interaction with the C-terminal peptides from Neurexin and BcrHeyue Zhou, Yingqi Xu, Yuedong Yang, et al.
New Biotechnology|April 12, 2011
Recombinant antibody libraries and selection technologiesHeyue Zhou, Yan-Liang Zhang, Guodi Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Selection and characterization of a human monoclonal neutralizing antibody for Clostridium Botulinum neurotoxin serotype BHeyue Zhou, Bin Zhou, Sabine Pellett, et al.
Biotechnology and Applied Biochemistry|September 21, 2002
A new method for the preparation of human parathyroid hormone 1-34 peptidesZhaoyang Xiu, Min Li, Suijing Zhou, et al.
FEBS Letters|April 9, 2008
Delineating the susceptibility of botulinum neurotoxins to denaturation through thermal effectsBin Zhou, Sabine Pellett, William H Tepp, et al.
Bioorganic & Medicinal Chemistry Letters|November 12, 2017
PSMA-targeted bispecific Fab conjugates that engage T cellsJames T Patterson, Jason Isaacson, Lisa Kerwin, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2017
Chemically generated IgG2 bispecific antibodies through disulfide bridgingJames T Patterson, Edwige Gros, Heyue Zhou, et al.
Frontiers in Oncology|June 6, 2022
A Novel Affinity Engineered Anti-CD47 Antibody With Improved Therapeutic Index That Preserves Erythrocytes and Normal Immune CellsYoug R Thaker, Ianne Rivera, Christophe Pedros, et al.
Cancer Research Communications|September 18, 2024
Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple MyelomaAaron D Springer, Rengang Wang, Jiawei Wang, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|September 4, 2007
Selection and characterization of human monoclonal antibodies against Abrin by phage displayHeyue Zhou, Bin Zhou, Hongzheng Ma, et al.
The Journal of Biological Chemistry|February 3, 2005
Solution structure of AF-6 PDZ domain and its interaction with the C-terminal peptides from Neurexin and BcrHeyue Zhou, Yingqi Xu, Yuedong Yang, et al.
New Biotechnology|April 12, 2011
Recombinant antibody libraries and selection technologiesHeyue Zhou, Yan-Liang Zhang, Guodi Lu, et al.
Bioorganic & Medicinal Chemistry Letters|December 30, 2008
Selection and characterization of a human monoclonal neutralizing antibody for Clostridium Botulinum neurotoxin serotype BHeyue Zhou, Bin Zhou, Sabine Pellett, et al.
Biotechnology and Applied Biochemistry|September 21, 2002
A new method for the preparation of human parathyroid hormone 1-34 peptidesZhaoyang Xiu, Min Li, Suijing Zhou, et al.
FEBS Letters|April 9, 2008
Delineating the susceptibility of botulinum neurotoxins to denaturation through thermal effectsBin Zhou, Sabine Pellett, William H Tepp, et al.
Bioorganic & Medicinal Chemistry Letters|November 12, 2017
PSMA-targeted bispecific Fab conjugates that engage T cellsJames T Patterson, Jason Isaacson, Lisa Kerwin, et al.
Bioorganic & Medicinal Chemistry Letters|July 20, 2017
Chemically generated IgG2 bispecific antibodies through disulfide bridgingJames T Patterson, Edwige Gros, Heyue Zhou, et al.
Frontiers in Oncology|June 6, 2022
A Novel Affinity Engineered Anti-CD47 Antibody With Improved Therapeutic Index That Preserves Erythrocytes and Normal Immune CellsYoug R Thaker, Ianne Rivera, Christophe Pedros, et al.
Cancer Research Communications|September 18, 2024
Preclinical Evaluation of STI-8811, a Novel Antibody-Drug Conjugate Targeting BCMA for the Treatment of Multiple MyelomaAaron D Springer, Rengang Wang, Jiawei Wang, et al.
Pageof 2